HIV can be flushed out of its hiding places in the body using a
cancer drug, researchers show.
The cornerstone of treatment, anti-retroviral therapy, kills the virus in
the bloodstream but leaves "HIV reservoirs" untouched.
The study, published in PLoS Pathogens, showed the drug was "highly
potent" at reactivating hidden HIV.
Experts said the findings were interesting, but it was important to know
if the drug was safe in patients.
The power of the HIV reservoir was shown with the case of the
Mississippi baby.
She was given antiretroviral drugs at birth. Despite appearing to be free
of HIV for nearly two years after stopping treatment, she was found to
be harbouring the virus.
'Kick and kill'
A strategy known as "kick and kill" is thought to be key to curing HIV -
the kick would wake up the dormant HIV allowing the drugs to kill it.
The team at the UC Davis School of Medicine investigated PEP005 - one
of the ingredients in a treatment
to prevent cancer in sun-damaged
skin.
They tested the drug in cells grown in the laboratory and in parts of the
immune system taken from 13 people with HIV.
The report said "PEP005 is highly potent in reactivating latent HIV" and
that the chemical represents "a new group of lead compounds for
combating HIV".
One of the researchers, Dr Satya Dandekar, said: "We are excited to
have identified an outstanding candidate for HIV reactivation and
eradication that is already approved and is being used in patients.
"This molecule has great potential to advance into translational and
clinical studies."
However, the drug has still not been tested in people who are HIV-
positive.
Prof Sharon Lewin, from the University of Melbourne, said the results
were "interesting" and marked an "important advance in finding new
compounds that can activate latent HIV".
She told the BBC: "This study adds another family of drugs to test to
potentially eliminate long-lived forms of HIV although much more work
needs to be done to see if this works in patients.
"Although PEP005 is part of an FDA approved drug, it will first take
some time to work out if it is safe to use in the setting of HIV."
http://www.bbc.com/news/health

ok

.